The PI3K/AKT pathway is an important signaling pathway for drug resistance in various cancers such as melanoma, lung cancer, ovarian cancer, leukemia, and hepatocellular carcinoma (Chen et al. 2018a, b; Rittler et al. 2019; Soltani et al. 2019). Here, AKT1 is linked to leukemia.